0000947871-23-000911.txt : 20230830 0000947871-23-000911.hdr.sgml : 20230830 20230830170812 ACCESSION NUMBER: 0000947871-23-000911 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Galecto, Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39655 FILM NUMBER: 231226051 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: OrbiMed Advisors Israel II Ltd CENTRAL INDEX KEY: 0001682093 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 144 1 primary_doc.xml 144 0001682093 XXXXXXXX LIVE 0001800315 Galecto, Inc. 001-39655 75 State Street Suite 100 Boston MA 02109 45-70-70-52-10 OrbiMed Israel Partners II, L.P. Shareholder Common Stock Bank of America

One Bryant Park New York NY 10036

510610 296154.00 27112697 08/30/2023 Nasdaq Stock Market Common Stock 10/23/2018 Private placement Issuer N 510610 10/23/2018 Cash N OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 07/13/2023 52800 126720.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 07/25/2023 4700 13724.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 07/31/2023 29700 89100.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/15/2023 248819 186614.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/21/2023 20517 12792.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/22/2023 12703 7873.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/23/2023 26443 16705.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/24/2023 20077 12389.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/25/2023 11565 6948.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/28/2023 9210 5135.00 OrbiMed Israel Partners II, L.P.

5 Hahoshlim St. Building B, 1st Floor Herzliya Pituach L3 4672405

Common Stock 08/29/2023 17541 10070.00 OrbiMed Israel GP II, L.P. is the general partner of OrbiMed Israel Partners II, L.P. OrbiMed Advisors Israel II Limited is the general partner of OrbiMed Israel GP II, L.P. 08/30/2023 /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Israel Partners II, L.P.